By Sophie Sassard, Olivia Oran and Soyoung Kim LONDON/NEW YORK (Reuters) - Sanofi SA is looking to sell a portfolio of older drugs that could fetch $7-8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas. The French pharmaceutical firm has hired financial advisers Evercore Partners Inc to help it with a deal and has contacted potential buyers in the past few months, the people said, asking not to be named because the matter is private. Shares in Sanofi rose 1.5 percent in early trade on Wednesday following the news. Generic drugmakers and specialty pharmaceutical companies are seen as logical buyers for the portfolio, said the people familiar with the matter.
via Health News Headlines - Yahoo News http://ift.tt/1hQU1HI
No comments:
Post a Comment